share_log

Intelligent Bio Solutions | 8-K: Current report

SEC announcement ·  Apr 12 20:32
Summary by Futu AI
Intelligent Bio Solutions Inc., a medical technology company listed on Nasdaq under the symbol INBS, announced on April 11, 2024, the expansion of its intellectual property portfolio with the grant of a new European patent for its subsidiary, Intelligent Fingerprinting Limited. The patent, which has unitary effect, covers the DSR-Plus Cartridge Reader, a device that facilitates non-invasive, rapid drug screening through fingerprint sweat analysis. This technology is particularly useful in workplace and safety-critical environments. The European patent enables the company to enforce its rights in 17 European countries, marking a significant step in Intelligent Bio Solutions' strategy to expand its global presence and offer its advanced solutions to a wider market. The company's CEO, Harry Simeonidis, expressed enthusiasm for the expansion into the European market and the potential to enhance workplace safety and health. The DSR-Plus Cartridge Reader is noted for its efficiency, providing results in less than ten minutes, and is part of the company's broader aim to revolutionize portable testing across various applications.
Intelligent Bio Solutions Inc., a medical technology company listed on Nasdaq under the symbol INBS, announced on April 11, 2024, the expansion of its intellectual property portfolio with the grant of a new European patent for its subsidiary, Intelligent Fingerprinting Limited. The patent, which has unitary effect, covers the DSR-Plus Cartridge Reader, a device that facilitates non-invasive, rapid drug screening through fingerprint sweat analysis. This technology is particularly useful in workplace and safety-critical environments. The European patent enables the company to enforce its rights in 17 European countries, marking a significant step in Intelligent Bio Solutions' strategy to expand its global presence and offer its advanced solutions to a wider market. The company's CEO, Harry Simeonidis, expressed enthusiasm for the expansion into the European market and the potential to enhance workplace safety and health. The DSR-Plus Cartridge Reader is noted for its efficiency, providing results in less than ten minutes, and is part of the company's broader aim to revolutionize portable testing across various applications.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.